How many studies have been conducted on Fidaxomicin?

BiohacksAI has indexed 295 PubMed studies on Fidaxomicin, including 20 randomized controlled trials (RCTs). 62% of studies involve human subjects.

What are the main research areas for Fidaxomicin?

The primary research domains for Fidaxomicin are 🦠 Gut & Microbiome, 🔬 Oncology, 🔬 Inflammation. This is based on analysis of 295 PubMed studies using the BiohacksAI evidence platform.

Fidaxomicin

A narrow-spectrum macrolide antibacterial agent that is used in the treatment of diarrhea associated with CLOSTRIDIUM DIFFICILE INFECTION.

295+ PubMed studies analyzed · 20 RCTs · Evidence Score: 56.1

Research Domains

Fidaxomicin has been studied across 7 research domains including 🦠 Gut & Microbiome, 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity, ⚡ Energy & Fatigue. The primary research focus is 🦠 Gut & Microbiome with 16% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Fidaxomicin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Loading evidence profile...

This evidence profile for Fidaxomicin is generated deterministically from 295 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.